city New Delhi India covid-19 testing vaccine city New Delhi India

Two doses of Covaxin 50% effective against symptomatic covid-19: Lancet

Reading now: 996

NEW DELHI : Two doses of Bharat Biotech's Covaxin result in 50% effectiveness against symptomatic covid-19, as per the first real-world assessment of the India-developed vaccine, published in The Lancet Infectious Diseases journal.

The study was conducted during India’s second covid-19 surge in a high-exposure population (healthcare workers). The researchers assessed 2,714 hospital workers from the All India Institute of Medical Sciences (AIIMS) in Delhi, India, from April 15 to May 15, 2021, who were symptomatic and underwent RT-PCR testing for covid-19.

The delta variant was the dominant strain in India during the study period, accounting for approximately 80% of all confirmed covid-19 cases. “Our study offers a more complete picture

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News